NICE supports Humira and Remicade for Crohn's disease « pharma news
Dr Carole Longson, Health Technology Evaluation Centre Director, said: “These treatments are not suitable for all people with Crohn's disease. How...
Dr Carole Longson, Health Technology Evaluation Centre Director, said: “These treatments are not suitable for all people with Crohn’s disease. However, it is clear that infliximab and adalimumab may provide benefit to some severely ill …
Go here to read the rest:
NICE supports Humira and Remicade for Crohn's disease « pharma news
